Patents Assigned to Ceva Santé Animale
  • Patent number: 12036275
    Abstract: Described is a vaccine composition comprising an effective amount of at least one polypeptide selected from the group of IdeSsuis, rIdeSsuis, an analogue or a fragment thereof, or a polynucleotide encoding the same. This vaccine composition is used in the prophylactic, metaphylactic or therapeutic treatment of a Streptococcus suis infections in pigs or humans.
    Type: Grant
    Filed: August 5, 2020
    Date of Patent: July 16, 2024
    Assignee: Ceva Santé Animale S.A.
    Inventors: Jana Seele, Christoph Baums, Peter Valentin-Weigand
  • Patent number: 11134685
    Abstract: The invention relates to novel veterinary compositions comprising an effective amount of a neonicotinoid compound and an effective amount of a N-arylpyrazole compound. The invention also relates to the use of such compositions for controlling ectoparasites in a non-human mammal.
    Type: Grant
    Filed: January 29, 2020
    Date of Patent: October 5, 2021
    Assignee: Ceva Santé Animale
    Inventors: Hamadi Karembe, Marie Varloud
  • Patent number: 11090270
    Abstract: The present invention is directed to palatable veterinary compositions made from one or more pharmaceutical active ingredients having a smell and/or a taste that is repulsive to animals, and a preparation method for preparing oral veterinary compositions. Various aspects of the present invention are related to preparing palatable veterinary compositions that comprises mixing one or more pharmaceutical active ingredients having a smell with one or more palatabilizing agents.
    Type: Grant
    Filed: January 29, 2020
    Date of Patent: August 17, 2021
    Assignee: Ceva Santé Animale
    Inventors: Laurence Peyrot, Florence Guimberteau
  • Patent number: 11020350
    Abstract: The present invention concerns palatable veterinary compositions made from one or more pharmaceutical active ingredients having a smell and/or a taste that is repulsive to animals, and a preparation method for preparing said oral veterinary compositions.
    Type: Grant
    Filed: June 1, 2013
    Date of Patent: June 1, 2021
    Assignee: Ceva Santé Animale
    Inventors: Laurence Peyrot, Florence Guimberteau
  • Patent number: 10952988
    Abstract: This invention relates to a method of controlling the spread of dirofilariosis, such as for example heartworm, by administering to at least one non-human animal infested with filarioid nematodes such as Dirofilaria spp or susceptible to have been infested with filarioid nematodes such as Dirofilaria spp, an effective dose of a combination of a neonicotinoid compound and a pyrethroid compound.
    Type: Grant
    Filed: July 8, 2016
    Date of Patent: March 23, 2021
    Assignee: Ceva Santé Animale
    Inventors: Marie Varloud, Elizabeth Hodgkins
  • Publication number: 20210015910
    Abstract: Described is a vaccine composition comprising an effective amount of at least one polypeptide selected from the group of IdeSsuis, rldeSsuis, an analogue or a fragment thereof, or a polynucleotide encoding the same. This vaccine composition is used in the prophylactic, metaphylactic or therapeutic treatment of a Streptococcus suis infections in pigs or humans.
    Type: Application
    Filed: August 5, 2020
    Publication date: January 21, 2021
    Applicant: Ceva Santé Animale S.A.
    Inventors: Jana Seele, Christoph Baums, Peter Valentin-Weigand
  • Publication number: 20200163339
    Abstract: The invention relates to novel veterinary compositions comprising an effective amount of a neonicotinoid compound and an effective amount of a N-arylpyrazole compound. The invention also relates to the use of such compositions for controlling ectoparasites in a non-human mammal.
    Type: Application
    Filed: January 29, 2020
    Publication date: May 28, 2020
    Applicant: Ceva Santé Animale
    Inventors: Hamadi Karembe, Marie Varloud
  • Publication number: 20200163891
    Abstract: The present invention concerns palatable veterinary compositions made from one or more pharmaceutical active ingredients having a smell and/or a taste that is repulsive to animals, and a preparation method for preparing said oral veterinary compositions.
    Type: Application
    Filed: January 29, 2020
    Publication date: May 28, 2020
    Applicant: Ceva Santé Animale
    Inventors: Laurence Peyrot, Florence Guimberteau
  • Publication number: 20180235926
    Abstract: This invention relates to a method of controlling the spread of dirofilariosis, such as for example heartworm, by administering to at least one non-human animal infested with filarioid nematodes such as Dirofilaria spp or susceptible to have been infested with filarioid nematodes such as Dirofilaria spp, an effective dose of a combination of a neonicotinoid compound and a pyrethroid compound.
    Type: Application
    Filed: July 8, 2016
    Publication date: August 23, 2018
    Applicant: Ceva Santè Animale
    Inventors: Marie Varloud, Elizabeth Hodgkins
  • Publication number: 20180213790
    Abstract: The invention relates to novel veterinary compositions comprising an effective amount of a neonicotinoid compound and an effective amount of a N-arylpyrazole compound. The invention also relates to the use of such compositions for controlling ectoparasites in a non-human mammal.
    Type: Application
    Filed: July 22, 2016
    Publication date: August 2, 2018
    Applicant: Ceva Santé Animale
    Inventors: Hamadi Karembe, Marie Varloud
  • Publication number: 20170136080
    Abstract: The invention relates to compositions and to the methods of administration thereof. More specifically, it relates to an optimised method for the administration of active agents to non-human mammals by means of topical application of pre-determined doses.
    Type: Application
    Filed: June 30, 2015
    Publication date: May 18, 2017
    Applicant: Ceva Santé Animale
    Inventors: Florence Guimberteau, Hamadi Karembe, Vassilios Kaltsatos, Gautier Barthelemy
  • Patent number: 8802209
    Abstract: Multi-layered plastic polymeric container useful for the storage and conservation of pharmaceutical compositions, sterile or non sterile, which comprises an inner layer and an outer layer, a gas barrier layer, and adhesive layers.
    Type: Grant
    Filed: June 12, 2008
    Date of Patent: August 12, 2014
    Assignee: Ceva Santé Animale
    Inventors: Sandrine Lacoste, Laurence Peyrot, Eliane Boivin